K.J. Harrison & Partners Inc cut its position in CVS Health Corporation (NYSE:CVS) by 0.6% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,225 shares of the pharmacy operator’s stock after selling 200 shares during the period. CVS Health Corporation accounts for about 1.6% of K.J. Harrison & Partners Inc’s holdings, making the stock its 11th largest position. K.J. Harrison & Partners Inc’s holdings in CVS Health Corporation were worth $2,989,000 as of its most recent SEC filing.
Several other hedge funds have also bought and sold shares of CVS. PGGM Investments acquired a new stake in CVS Health Corporation during the second quarter worth approximately $29,054,000. Deltec Asset Management LLC raised its stake in CVS Health Corporation by 8.6% in the second quarter. Deltec Asset Management LLC now owns 67,000 shares of the pharmacy operator’s stock worth $6,415,000 after buying an additional 5,300 shares during the last quarter. HL Financial Services LLC raised its stake in CVS Health Corporation by 3.6% in the second quarter. HL Financial Services LLC now owns 1,390,283 shares of the pharmacy operator’s stock worth $133,106,000 after buying an additional 48,092 shares during the last quarter. RS Investment Management Co. LLC raised its stake in CVS Health Corporation by 13.3% in the second quarter. RS Investment Management Co. LLC now owns 897,935 shares of the pharmacy operator’s stock worth $85,968,000 after buying an additional 105,180 shares during the last quarter. Finally, Grimes & Company Inc. acquired a new stake in CVS Health Corporation during the second quarter worth approximately $243,000. 80.96% of the stock is owned by institutional investors and hedge funds.
Shares of CVS Health Corporation (NYSE:CVS) traded up 0.34% during midday trading on Thursday, reaching $86.49. The company’s stock had a trading volume of 5,267,005 shares. The stock has a market capitalization of $92.22 billion, a PE ratio of 19.90 and a beta of 0.83. The company has a 50 day moving average price of $91.72 and a 200-day moving average price of $97.02. CVS Health Corporation has a 52 week low of $85.89 and a 52 week high of $106.67.
CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.30 by $0.02. The company had revenue of $43.70 billion for the quarter, compared to the consensus estimate of $44.28 billion. CVS Health Corporation had a return on equity of 15.86% and a net margin of 2.88%. The firm’s revenue for the quarter was up 17.6% compared to the same quarter last year. During the same period last year, the firm earned $1.19 EPS. On average, equities research analysts expect that CVS Health Corporation will post $5.86 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 3rd. Stockholders of record on Monday, October 24th will be given a dividend of $0.425 per share. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.97%. The ex-dividend date of this dividend is Thursday, October 20th. CVS Health Corporation’s dividend payout ratio (DPR) is presently 39.08%.
A number of research firms have commented on CVS. Vetr lowered CVS Health Corporation from a “strong-buy” rating to a “hold” rating and set a $87.73 target price for the company. in a report on Thursday. Credit Suisse Group AG reaffirmed an “outperform” rating and issued a $110.00 price objective (down previously from $115.00) on shares of CVS Health Corporation in a report on Tuesday. Robert W. Baird cut their price objective on CVS Health Corporation from $114.00 to $104.00 and set an “outperform” rating for the company in a report on Monday. Leerink Swann reaffirmed an “outperform” rating and issued a $105.00 price objective (down previously from $110.00) on shares of CVS Health Corporation in a report on Sunday. Finally, Mizuho reaffirmed a “buy” rating and issued a $111.00 price objective on shares of CVS Health Corporation in a report on Friday, September 30th. Six equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $112.11.
CVS Health Corporation Company Profile
CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.